BOK
TEVA icon

Bank of Kentucky’s Teva Pharmaceuticals TEVA Stock Holding History

Bank of Kentucky’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,020
Closed -$41K – 298
2013
Q4 		$41K Hold
1,020
– – 0.01% 163
2013
Q3 		$39K Buy
1,020
+320
+46% +$12.5K 0.01% 165
2013
Q2 		$28K Buy
+700
New +$27.3K 0.01% 178

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Bank of Kentucky's TEVA Position: Q1 2014 in Review

Bank of Kentucky sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 1,020 shares — an estimated $41K sold.

Bank of Kentucky first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $41K in Q4 2013. 771 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Bank of Kentucky reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Bank of Kentucky sold 1,020 Teva Pharmaceuticals shares in Q1 2014, an estimated $41K.
  • Bank of Kentucky first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Bank of Kentucky's Teva Pharmaceuticals position peaked at $41K in Q4 2013.
  • 771 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Bank of Kentucky's 13F filing for Q1 2014, filed 19 May 2014.